Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort

Gastroenterology

Volumn 139, Issue 4, 2010, Pages 1147-1155

  Thia, Kelvin T ^a,b   Sandborn, William J ^a   Harmsen, William S ^a   Zinsmeister, Alan R ^a   Loftus Jr , Edward V ^a  

^a MAYO CLINIC   (United States)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Abscess; Complications; Crohns Disease; Fistula; Natural History; Stricture

Indexed keywords

ADOLESCENT; ADULT; AGED; ANUS DISEASE; ARTICLE; COHORT ANALYSIS; COLON CROHN DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PHENOTYPE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; UNITED STATES; CHILD; COMPLICATION; MIDDLE AGED; SMOKING; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COHORT STUDIES; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SMOKING;

EID: 77957346794     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.06.070     Document Type: Article

References (36)

1. C. Gasche, J. Scholmerich, and J. Brynskov A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 Inflamm Bowel Dis 6 2000 8 15
2. D.K. Chow, R.W. Leong, and L.H. Lai Changes in Crohn's disease phenotype over time in the Chinese population: validation of the Montreal classification system Inflamm Bowel Dis 14 2008 536 541
3. J. Cosnes, S. Cattan, and A. Blain Long-term evolution of disease behavior of Crohn's disease Inflamm Bowel Dis 8 2002 244 250
4. H.J. Freeman Natural history and clinical behavior of Crohn's disease extending beyond two decades J Clin Gastroenterol 37 2003 216 219
5. E. Louis, A. Collard, and A.F. Oger Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease Gut 49 2001 777 782
6. P. Nos, V. Garrigues, G. Bastida, N. Maroto, M. Ponce, and J. Ponce Outcome of patients with nonstenotic, nonfistulizing Crohn's disease Dig Dis Sci 49 2004 1771 1776
7. I.C. Solberg, M.H. Vatn, and O. Hoie Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study Clin Gastroenterol Hepatol 5 2007 1430 1438
8. K.M. Tarrant, M.L. Barclay, C.M. Frampton, and R.B. Gearry Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype Am J Gastroenterol 103 2008 3082 3093
9. J. Cosnes, I. Nion-Larmurier, L. Beaugerie, P. Afchain, E. Tiret, and J.P. Gendre Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery Gut 54 2005 237 241
10. P. Rutgeerts, R.H. Diamond, and M. Bala Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease Gastrointest Endosc 63 2006 433 442
11. B.G. Feagan, R. Panaccione, and W.J. Sandborn Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study Gastroenterology 135 2008 1493 1499
12. G.R. Lichtenstein, S. Yan, M. Bala, M. Blank, and B.E. Sands Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease Gastroenterology 128 2005 862 869
13. G. D'Haens, F. Baert, and G. van Assche Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial Lancet 371 2008 660 667
14. W.A. Faubion Jr, E.V. Loftus Jr, W.S. Harmsen, A.R. Zinsmeister, and W.J. Sandborn The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study Gastroenterology 121 2001 255 260
15. D.A. Schwartz, E.V. Loftus Jr, and W.J. Tremaine The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota Gastroenterology 122 2002 875 880
16. M.S. Silverberg, J. Satsangi, and T. Ahmad Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology Can J Gastroenterol 19 Suppl A 2005 5 36
17. L.J. Melton 3rd History of the Rochester Epidemiology Project Mayo Clin Proc 71 1996 266 274
18. J.H. Gollop, S.F. Phillips, L.J. Melton 3rd, and A.R. Zinsmeister Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 19431982 Gut 29 1988 49 56
19. S.B. Ingle, E.V. Loftus Jr, W.J. Tremaine, W.S. Harmsen, A.R. Zinsmeister, L.J. Melton, and W.J. Sandborn Increasing incidence and prevalence of inflammatory bowel disease in Olmsted County, Minnesota, 20012004 (abstract) Gastroenterology 132 Suppl 2 2007 A19 A20
20. C.G. Loftus, E.V. Loftus Jr, and W.S. Harmsen Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 19402000 Inflamm Bowel Dis 13 2007 254 261
21. E.V. Loftus Jr, M.D. Silverstein, W.J. Sandborn, W.J. Tremaine, W.S. Harmsen, and A.R. Zinsmeister Crohn's disease in Olmsted County, Minnesota, 19401993: incidence, prevalence, and survival Gastroenterology 114 1998 1161 1168
22. R.E. Sedlack, J. Whisnant, L.R. Elveback, and L.T. Kurland Incidence of Crohn's disease in Olmsted County, Minnesota, 19351975 Am J Epidemiol 112 1980 759 763
23. F.L. Wolters, M.G. Russel, and J. Sijbrandij Phenotype at diagnosis predicts recurrence rates in Crohn's disease Gut 55 2006 1124 1130
24. E.V. Loftus Jr Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences Gastroenterology 126 2004 1504 1517
25. L.E. Oostenbrug, H.M. van Dullemen, G.J. te Meerman, P.L. Jansen, and J.H. Kleibeuker Clinical outcome of Crohn's disease according to the Vienna classification: disease location is a useful predictor of disease course Eur J Gastroenterol Hepatol 18 2006 255 261
26. B.R. Smith, I.D. Arnott, H.E. Drummond, E.R. Nimmo, and J. Satsangi Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease Inflamm Bowel Dis 10 2004 521 528
27. F.T. Veloso, J.T. Ferreira, L. Barros, and S. Almeida Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity Inflamm Bowel Dis 7 2001 306 313
28. M.C. Aldhous, H.E. Drummond, N. Anderson, L.A. Smith, I.D. Arnott, and J. Satsangi Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification Am J Gastroenterol 102 2007 577 588
29. E. Louis, V. Michel, and J.P. Hugot Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype Gut 52 2003 552 557
30. D.C. Baumgart, and W.J. Sandborn Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 2007 1641 1657
31. O.O. Thomsen, A. Cortot, and D. Jewell A comparison of budesonide and mesalamine for active Crohn's disease International Budesonide-Mesalamine Study Group N Engl J Med 339 1998 370 374
32. L.Y. Tang, P. Rawsthorne, and C.N. Bernstein Are perineal and luminal fistulas associated in Crohn's disease? A population-based study Clin Gastroenterol Hepatol 4 2006 1130 1134
33. L. Beaugerie, P. Seksik, I. Nion-Larmurier, J.P. Gendre, and J. Cosnes Predictors of Crohn's disease Gastroenterology 130 2006 650 656
34. J. Cosnes, F. Carbonnel, L. Beaugerie, Y. Le Quintrec, and J.P. Gendre Effects of cigarette smoking on the long-term course of Crohn's disease Gastroenterology 110 1996 424 431
35. T. Yamamoto, and M.R. Keighley Smoking and disease recurrence after operation for Crohn's disease Br J Surg 87 2000 398 404
36. C. Gasche, and P. Grundtner Genotypes and phenotypes in Crohn's disease: do they help in clinical management? Gut 54 2005 162 167